Quantum-Si incorporated
NASDAQ:QSIBiotechnology
Healthcare
$1.01 +5.02%
+$0.05 today
- Market cap
- $201.80M
- Beta
- 3.17
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$0.48
52W Low $0.69High $3.10
Volume 5.35M
Average 5.64M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$94.72M
FY 2025 · Annual
Investing Cash Flow
-$28.32M
FY 2025 · Annual
Financing Cash Flow
$95.42M
FY 2025 · Annual
+166.0% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (94.99M) | (132.44M) | (95.96M) | (101.01M) | (101.34M) |
| Depreciation & Amortization | 1.04M | 2.58M | 4.16M | 4.6M | 4.45M |
| Deferred Income Tax | 714K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 24.92M | 11.21M | 8.52M | 8.89M | 10.77M |
| Change in Working Capital | 1.47M | 3.05M | (3.2M) | 4.64M | (4.58M) |
| Accounts Receivables | 0 | 0 | (368K) | (1.09M) | 626K |
| Inventory | 0 | 0 | 286K | 4.34M | (2.01M) |
| Accounts Payables | 709K | 721K | (1.22M) | 390K | (338K) |
| Other Working Capital | 758K | 2.33M | (1.89M) | 1M | (2.86M) |
| Other Non-Cash Items | 36K | 25.04M | (7.55M) | (4.92M) | (4.03M) |
| Operating Cash Flow | (66.81M) | (90.56M) | (94.04M) | (87.8M) | (94.72M) |
| Capital Expenditures | (5.76M) | (10.74M) | (5.27M) | (4.58M) | (2.52M) |
| Acquisitions (Net) | (4.63M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (440.54M) | (834K) | (123.81M) | (369.43M) | (404.58M) |
| Sales of Investments | 445.17M | 148.76M | 272.51M | 341.4M | 378.78M |
| Other Investing Activities | (445.17M) | 0 | (763K) | (59K) | 0 |
| Investing Cash Flow | (450.94M) | 137.19M | 143.43M | (32.68M) | (28.32M) |
| Debt Repayment | (1.78M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 512.79M | 2.76M | 0 | 34.79M | 95.42M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.61M | (848K) | 149K | 1.09M | 1K |
| Financing Cash Flow | 516.63M | 1.91M | 149K | 35.88M | 95.42M |
| Effect of Forex Changes | 0 | 0 | 0 | (25K) | 12K |
| Net Change in Cash | (1.13M) | 48.53M | 49.54M | (84.62M) | (27.6M) |
| Free Cash Flow | (72.58M) | (101.3M) | (99.31M) | (92.38M) | (97.23M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$101.3M
+ D&A$4.5M
+ Stock-Based Comp$10.8M
+ Deferred Tax$0
- Working Capital-$4.6M
- Other Non-Cash-$4.0M
= Operating Cash Flow-$94.7M
- Capex-$2.5M
= Free Cash Flow-$97.2M
Analysis
FY2025 free cash flow is -$97.2M. FCF conversion is 95.9% of net income. Operating cash flow was -$94.7M, with capex of -$2.5M. The largest bridge item is Stock-Based Comp at $10.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 8-K | Current report | Oct 15, 2026 | |
| 8-K | Current report | Oct 8, 2026 | |
| 8-K | Current report | Sep 29, 2026 |
Does QSI generate free cash flow?
Quantum-Si incorporated (QSI) generated -$97.23M of free cash flow in fiscal 2025.
How much operating cash flow does QSI produce?
Operating cash flow was -$94.72M, before capital expenditures of $2.52M.
Continue the stock analysis
Jump to another research area for this company.